{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:26:09Z","timestamp":1648740369893},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T00:00:00Z","timestamp":1378339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00120-013-3171-z","type":"journal-article","created":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T10:25:11Z","timestamp":1378203911000},"page":"1406-1415","source":"Crossref","is-referenced-by-count":1,"title":["Aktuelle Therapieoptionen der Induratio penis plastica"],"prefix":"10.1007","volume":"52","author":[{"given":"A.","family":"Hauptmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Diemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"key":"3171_CR1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","volume":"69","author":"Bennet","year":"2007","unstructured":"Bennet NE, Guhring P, Mulhall JP (2007) Intralesional verapamil prevents the progression of Peyronie\u2019s disease. J Urol 69:1181\u20131184","journal-title":"J Urol"},{"key":"3171_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ncpuro0409","volume":"3","author":"Brant","year":"2006","unstructured":"Brant WO, Dean RC, Lue TF (2006) Treatment of Peyronie\u2019s disease with oral pentoxifylline. Nat Clin Pract Urol 3:111\u2013115","journal-title":"Nat Clin Pract Urol"},{"key":"3171_CR3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1464-410X.2002.02738.x","volume":"89","author":"Cavallini","year":"2002","unstructured":"Cavallini G, Biagiotti G, Koverech A, Vitali G (2002) Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie\u2019s disease. BJU Int 89:895\u2013900","journal-title":"BJU Int"},{"key":"3171_CR4","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1743-6109.2011.02217.x","volume":"8","author":"Chung","year":"2011","unstructured":"Chung E, Deyoung L, Brock GB (2011) Thew role of PDE5 inhibitors in penile septal scar modeling: assessment of clinical and radiological outcomes. J Sex Med 8:1472\u20131477","journal-title":"J Sex Med"},{"key":"3171_CR5","first-page":"165","volume":"70","author":"Cipollone","year":"1998","unstructured":"Cipollone G, Nicolai M, Mastroprimiano G et al (1998) Betamethason versus placebo in Peyronie\u2019s disease. Arch Ital Urol Androl 70:165\u2013168","journal-title":"Arch Ital Urol Androl"},{"key":"3171_CR6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0090-4295(85)90285-7","volume":"25","author":"Essed","year":"1985","unstructured":"Essed E, Schroeder F (1985) New surgical treatment for Peyronie\u2019s disease. Urology 25:582\u2013587","journal-title":"Urology"},{"key":"3171_CR7","doi-asserted-by":"crossref","unstructured":"Gelbard M, Goldstein I, Hellstrom WJG et al (2013) Clinical efficacy, safety, and tolerability of collagenase clostridium histolyticum in the treatment of Peyronie\u2019s disease from 2 large double-blind, randomized, placebo-controlled phase 3 studies. J Urol (im Druck)","DOI":"10.1016\/j.juro.2013.01.087"},{"key":"3171_CR8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1743-6109.2008.01108.x","volume":"6","author":"Gontero","year":"2009","unstructured":"Gontero P, Di Marco M, Guibilei G et al (2009) Use of penile extender device in the treatment of penile curvature as a result of Peyronie\u2019s disease. Results of a phase II prospective study. J Sex Med 6:558\u2013566","journal-title":"J Sex Med"},{"key":"3171_CR9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrurol.2010.24","volume":"7","author":"Gonzales-Cadavid","year":"2010","unstructured":"Gonzales-Cadavid NF, Rajfer J (2010) Treatment of Peyronie\u2019s disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol 7(4):215\u2013221","journal-title":"Nat Rev Urol"},{"key":"3171_CR10","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.juro.2006.10.065","volume":"177","author":"Greenfield","year":"2007","unstructured":"Greenfield JM, Shah SJ, Levine LA (2007) Verapamil verus saline in electromotive drug administration for Peyronie\u2019s disease: a double-blind, placebo controlled trial. J Urol 177:972\u2013975","journal-title":"J Urol"},{"key":"3171_CR11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.mehy.2011.11.008","volume":"78","author":"Gur","year":"2012","unstructured":"Gur S, Kadowitz PJ, Hellstrom WJG (2012) Drugs of the future for Peyronie\u2019s disease. Med Hypotheses 78:305\u2013311","journal-title":"Med Hypotheses"},{"key":"3171_CR12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","volume":"62","author":"Hatzimouratidis","year":"2012","unstructured":"Hatzimouratidis K, Eardley I, Giuliano F et al (2012) EAU guidelines on penile curvature. Eur Urol 62:543\u2013552","journal-title":"Eur Urol"},{"key":"3171_CR13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.eururo.2006.02.059","volume":"49","author":"Hauck","year":"2006","unstructured":"Hauck EW, Diemer T, Schmelz HU, Weidner W (2006) A critical analysis of nonsurgical treatment of Peyronie\u2019s disease. Eur Urol 49:987\u2013997","journal-title":"Eur Urol"},{"key":"3171_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0302-2838(03)00003-4","volume":"43","author":"Hauck","year":"2003","unstructured":"Hauck EW, Hackstein N, Vosshenrich R et al (2003) Diagnostic value of magnetic resonance imaging in Peyronie\u2019s disease \u2013 a comparison both with palpation and urltrasound in the evalutation of plaque formation. Eur Urol 43:293\u2013300","journal-title":"Eur Urol"},{"key":"3171_CR15","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(00)05119-9","volume":"357","author":"Hauck","year":"2001","unstructured":"Hauck EW, Weidner W (2001) Fran\u00e7ois de la Peyronie and the disease named after him. Lancet 357:2049\u20132051","journal-title":"Lancet"},{"key":"3171_CR16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00120-011-2517-7","volume":"50","author":"Hauptmann","year":"2011","unstructured":"Hauptmann A, Diemer T, Weidner W (2011) Induratio penis plastica: Diagnostik und Therapie. Urologe A 50(5):609\u2013620","journal-title":"Urologe A"},{"key":"3171_CR17","doi-asserted-by":"crossref","unstructured":"Hellstrom WJG, Feldman R, Rosen RC et al (2013) Bother and distress associated with Peyronie\u2019s disease: validation of the Peyronie\u2019s Disease Questionaire (PDQ). J Urol (published online 02\/2013)","DOI":"10.1016\/j.yuro.2013.04.012"},{"key":"3171_CR18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","volume":"176","author":"Hellstrom","year":"2006","unstructured":"Hellstrom WJG, Kendirci M, Matern R et al (2006) Single-Blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon-alpha2b for minimally invasive treatment for Peyronie\u2019s disease. J Urol 176:394\u2013398","journal-title":"J Urol"},{"key":"3171_CR19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1586\/14737167.4.2.235","volume":"4","author":"Incrocci","year":"2004","unstructured":"Incrocci L (2004) Radiotherapeutic treatment of Peyronie\u2019s disease. Expert Rev Pharmacoecon Outcomes Res 4:235\u2013242","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"3171_CR20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1743-6109.2007.00651.x","volume":"5","author":"Jordan","year":"2008","unstructured":"Jordan GH. (2008) The use of intralesional clostridial collagenase injection therapy for Peyronie\u2019s disease: a prospective, single center, non-placebo-controlled study. J Sex Med 5:180\u2013187","journal-title":"J Sex Med"},{"key":"3171_CR21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrurol.2010.233","volume":"8","author":"Kadioglu","year":"2011","unstructured":"Kadioglu A, K\u00fc\u00e7\u00fckdurmaz F, Sanli O (2011) Current status oft he surgical management of Peyronie\u2019s disease. Nat Rev Urol 8:95\u2013106","journal-title":"Nat Rev Urol"},{"key":"3171_CR22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1743-6109.2007.00461.x","volume":"4","author":"Kadioglu","year":"2007","unstructured":"Kadioglu A, Sanli O, Akman T et al (2007) Graft materials in Peyronie\u2019s disease surgery: a comprehenisve review. J Sex Med 4:581\u2013595","journal-title":"J Sex Med"},{"key":"3171_CR23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.ijir.3900519","volume":"12","author":"Kadioglu","year":"2000","unstructured":"Kadioglu A, Tefekli A, K\u00f6ksal T et al (2000) Treatment of Peyronie\u2019s disease with oral colchicine: long-term results and predictive parameters of successful outcome. Int J Impot Res 12:169\u2013175","journal-title":"Int J Impot Res"},{"key":"3171_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijir.2011.45","volume":"24","author":"Larsen","year":"2012","unstructured":"Larsen SM, Levine LA (2012) Review of non-surgical treatment options for Peyronie\u2019s disease. Int J Impot Res 24:1\u201310","journal-title":"Int J Impot Res"},{"key":"3171_CR25","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1743-6109.2008.00814.x","volume":"5","author":"Levine","year":"2008","unstructured":"Levine LA, Newell M, Taylor FL (2008) Penile traction therapy for treatment of Peyronie\u2019s disease: a single-center pilot study. J Sex Med 5:1468\u20131473","journal-title":"J Sex Med"},{"key":"3171_CR26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1743-6109.2004.10104.x","volume":"1","author":"Lue","year":"2004","unstructured":"Lue TF, Giuliano F, Montorsi F et al (2004) Summary of recommendations on sexual dysfunctions in men. J Sex Med 1:6\u201323","journal-title":"J Sex Med"},{"key":"3171_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.2047-2927.2012.00018.x","volume":"1","author":"Mehrsai","year":"2013","unstructured":"Mehrsai AR, Namdari F, Salavati A et al (2013) Comparison of transdermal electromotive adminstration of verapamil and dexamethasone versus intralesional injection for Peyronie\u2019s disease. Andrology 1:129\u2013132","journal-title":"Andrology"},{"key":"3171_CR28","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"Mulhall","year":"2004","unstructured":"Mulhall JP, Creech SD, Boorjian SA et al (2004) Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening. J Urol 171:2350\u20132353","journal-title":"J Urol"},{"key":"3171_CR29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1743-6109.2012.02677.x","volume":"9","author":"Mulhall","year":"2012","unstructured":"Mulhall JP, Hall M, Broderick GA, Incrocci L (2012) Radiation therapy in Peyronie\u2019s disease. J Sex Med 9:1435\u20131441","journal-title":"J Sex Med"},{"key":"3171_CR30","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","volume":"175","author":"Mulhall","year":"2006","unstructured":"Mulhall JP, Schiff J, Guhring P (2006) An analysis of the natural history of Peyronie\u2019s disease. J Urol 175:2115\u20132118","journal-title":"J Urol"},{"key":"3171_CR31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0022-5347(17)63751-0","volume":"93","author":"Nesbit","year":"1965","unstructured":"Nesbit R (1965) Congenital curvature of the phallus: report of three cases with description of corrective operation. J Urol 93:230\u2013232","journal-title":"J Urol"},{"key":"3171_CR32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","volume":"56","author":"Palmieri","year":"2009","unstructured":"Palmieri A, Imbimbo C, Longo N et al (2009) A first prospective, randomised, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie\u2019s disease. Eur Urol 56:363\u2013370","journal-title":"Eur Urol"},{"key":"3171_CR33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.2047-2927.2012.00007.x","volume":"1","author":"Paulis","year":"2013","unstructured":"Paulis G, Brancato T, D\u2019Ascenzo R et al (2013) Efficacy of vitamin E in the conservative treatment of Peyronie\u2019s disease: legend or reality? A controlled study of 70 cases. Andrology 1:120\u2013128","journal-title":"Andrology"},{"key":"3171_CR34","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1464-410X.2003.04134.x","volume":"91","author":"Prieto","year":"2003","unstructured":"Prieto CRM, Leva VME, Regueiro LJC et al (2003) Combined treatment with vitamine E and colchicine in the early stages of Peyronies disease. BJU Int 91:522\u2013524","journal-title":"BJU Int"},{"key":"3171_CR35","first-page":"41","volume":"9","author":"Pryor","year":"1983","unstructured":"Pryor JP, Farell CR (1983) Controlled clinical trial of vitamine E in Peyronie\u2019s disease. Prog Reprod Biol Med 9:41\u201345","journal-title":"Prog Reprod Biol Med"},{"key":"3171_CR36","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-410X.2010.09365.x","volume":"106","author":"Raheem","year":"2010","unstructured":"Raheem AA, Garaffa G, Raheem TA (2010) The role of vacuum pump therapy to mechanically straighten the penis in Peyronie\u2019s disease. BJU Int 106:1178\u20131180","journal-title":"BJU Int"},{"key":"3171_CR37","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01781.x","volume":"7","author":"Ralph","year":"2010","unstructured":"Ralph D, Gonzalez-Cadavid N, Mirone V et al (2010) The management of Peyronie\u2019s disease. Evidence-based 2010 guidelines. J Sex Med 7:2359\u20132374","journal-title":"J Sex Med"},{"key":"3171_CR38","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1464-410X.1992.tb15836.x","volume":"70","author":"Ralph","year":"1992","unstructured":"Ralph DJ, Brooks MD, Botazzo GF, Pryor JP (1992) The treatment of Peyronie\u2019s disease with tamoxifen. Br J Urol 70:648\u2013651","journal-title":"Br J Urol"},{"key":"3171_CR39","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1111\/j.1743-6109.2012.02675.x","volume":"9","author":"Rolle","year":"2012","unstructured":"Rolle L, Ceruti C, Timpano M et al (2012) A new, innovative lengthening surgical procedure for Peyronie\u2019s disease by penile prosthesis implantation with double dorsal-ventral patch graft: the \u201esliding technique\u201c. J Sex Med 9:2389\u20132395","journal-title":"J Sex Med"},{"key":"3171_CR40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-410X.2009.09041.x","volume":"106","author":"Safarinejad","year":"2010","unstructured":"Safarinejad MR, Asgari MA, Hosseini SY, Dadkhah F (2010) A double-blind, placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie\u2019s disease. BJU Int 106:240\u2013248","journal-title":"BJU Int"},{"key":"3171_CR41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","volume":"16","author":"Safarinejad","year":"2004","unstructured":"Safarinejad MR (2004) Therapeutic effects of colchicine in the management of Peyronies\u2019s disease: a randomized double-blind, placebo-controlled study. Int J Impot Res 16:238\u2013243","journal-title":"Int J Impot Res"},{"key":"3171_CR42","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.juro.2007.05.162","volume":"178","author":"Safarinejad","year":"2007","unstructured":"Safarinejad MR, Hosseini SY, Kolahi AA (2007) Comparison of vitamin E and propionyl-L-carnitine with early chronic Peyronie\u2019s disease: a double-blind, placebo controlled, randomized study. J Urol 178:1398\u20131403","journal-title":"J Urol"},{"key":"3171_CR43","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1111\/j.1743-6109.2012.02887.x","volume":"9","author":"Schwarzer","year":"2012","unstructured":"Schwarzer JU, Steinfatt H (2012) Tunica albuginea underlap \u2013 a new modifikation of the Nesbit procedure: description of the technique and preliminary results. J Sex Med 9:2970\u20132974","journal-title":"J Sex Med"},{"key":"3171_CR44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11255-009-9522-4","volume":"41","author":"Shirazi","year":"2009","unstructured":"Shirazi M, Haghpanah AR, Badiee M et al (2009) Effect of intralesional verapamil for treatment of Peyronie\u2019s disease: a randomized single-blind, placebo-controlled study. Int Urol Nephrol 41:467\u2013471","journal-title":"Int Urol Nephrol"},{"key":"3171_CR45","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0022-5347(05)68087-1","volume":"162","author":"Teloken","year":"1999","unstructured":"Teloken C, Rhoden EL, Grazziotin TM et al (1999) Tamoxifen vs. placebo in the treatment of Peyronie\u2019s diesase. J Urol 162:2003\u20132005","journal-title":"J Urol"},{"key":"3171_CR46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jsm.12115","volume":"10","author":"Trost","year":"2013","unstructured":"Trost LW, Baum N, Hellstrom JG (2013) Managing the difficult penile prosthesis patient. J Sex Med 10:893\u2013907","journal-title":"J Sex Med"},{"key":"3171_CR47","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1743-6109.2009.01214.x","volume":"6","author":"Vardi","year":"2009","unstructured":"Vardi Y, Levine LA, Chen J et al (2009) Is There a place for conservative treatment in Peyronie\u2019s disease? J Sex Med 6:903\u2013909","journal-title":"J Sex Med"},{"key":"3171_CR48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","volume":"47","author":"Weidner","year":"2005","unstructured":"Weidner W, Hauck EW, Schnitker J (2005) Potassium paraaminobenzoate (POTABA\u2122) in the treatment of Peyronie\u2019s disease: a prospective, placebo-controlled randomized study. Eur Urol 47:530\u2013536","journal-title":"Eur Urol"},{"key":"3171_CR49","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(17)32519-3","volume":"152","author":"Wilson","year":"1994","unstructured":"Wilson SK, Delk JR 2nd (1994) A new treatment of Peyronie\u2019s disease: modeling the penis over an inflatable penile prothesis. J Urol 152:1121\u20131123","journal-title":"J Urol"},{"key":"3171_CR50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.ijir.3900997","volume":"15","author":"Wiltink","year":"2003","unstructured":"Wiltink J, Hauck EW, Ph\u00e4doyanon M et al (2003) Validation of the German version of the IIEF in patients with erectile dysfunction, Peyronie\u2019s disease and controls. Int J Impot Res 15:192\u2013197","journal-title":"Int J Impot Res"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-013-3171-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-013-3171-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-013-3171-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T01:14:56Z","timestamp":1563844496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-013-3171-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1007\/s00120-013-3171-z","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]}}}